Elizabeth Garrett-Mayer, PhD, FASCO, FSCT
Vice President
Center for Research and Analytics (CENTRA) 

Dr. Garrett-Mayer’s department (CENTRA)leads the American Society of Clinical Oncology’s research efforts, including the TAPUR Study (a pragmatic basket trial of FDA approved targeted agents in patients with advanced cancer), the CDK Study (a PCORI-funded clinical trial comparing two dosing strategies for CDK4/6 inhibitors), and programs aimed at dose optimization, improving access to clinical trials, and oncology workforce issues. Prior to joining ASCO, she served on the faculty at Johns Hopkins in the Department of Oncology and then joined the faculty of the Medical University of South Carolina (MUSC) where she established the Biostatistics Shared Resource at the Hollings Cancer Center (HCC). 

She earned her PhD in Biostatistics from Johns Hopkins Bloomberg School of Public Health. Her publication record includes more than 350 peer-reviewed publications, primarily in clinical trial design methods and clinical cancer research. She serves on the board of The Society for Clinical Trials, has been a member of numerous NIH committees, NCI task forces and steering groups, Data Safety Monitoring Boards for NIH-supported clinical trials, and serves on the editorial board of three peer-reviewed journals. She has served as course director for both the ASCO-AACR Methods in Clinical Cancer Workshop and the Society for Immunotherapy of Cancer’s Clinical Immuno-Oncology Network Workshop.